Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
Apply
Trastuzumab Deruxtecan
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step